News and Trends 2 Dec 2022
Tris Pharma and Pediatrix Therapeutics extend partnership for ADHD portfolio
Tris Pharma, Inc announced today (December 2) that they have expanded their partnership allowing Pediatrix Therapeutics to receive exclusive rights to commercialize…